Dave Hanaman is co-founder, president, and chief commercial officer of Curavit Clinical Research, a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials and specializing in digital therapeutics. He is a proven entrepreneur, operator, and board director. Founder of C3i, a Business Process Outsourcing (BPO) healthcare provider, Hanaman developed and led its sales, marketing, product development, and alliance strategies. He serves as a board member and advisor to several start-up and growth-stage companies in healthcare and technology. Hanaman graduated from the University of California at Berkeley and served as a deployed U.S. Navy intelligence officer.
One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. During Covid-19, governing agencies loosened regulatory requirements and increased incentives for DTx. Fortunately, this propelled innovation, and transitioned DTx from up-and-coming to a high-demand field. The goal was […]